These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23772497)

  • 1. [Diabetes mellitus related common medical disorders : recent progress in diagnosis and treatment. Topics: I. Pathophysiology, diagnosis and treatment: 3. Primary aldosteronism, resistant hypertension and diabetes mellitus].
    Shibata H; Itoh H
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):850-5. PubMed ID: 23772497
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary aldosteronism and diabetes mellitus.
    Steichen O
    Horm Metab Res; 2010 Sep; 42(10):758-9; author reply 760. PubMed ID: 20648412
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence and Uncertainties Surrounding Renin-Guided Medical Therapy for Primary Aldosteronism.
    Hiremath S; Hundemer GL
    Am J Hypertens; 2023 Jul; 36(8):428-430. PubMed ID: 37061828
    [No Abstract]   [Full Text] [Related]  

  • 4. [Primary aldosteronism is an underdiagnosed cause of hypertension. Important to find undiagnosed patients--effective treatment available].
    Ragnarsson O; Muth A; Johannsson G; Wängberg B
    Lakartidningen; 2015 Dec; 112():. PubMed ID: 26625102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identify and treat aldosteronism to control hypertension. The condition, characterized by water retention, makes high blood pressure hard to control and raises cardiovascular risks.
    Heart Advis; 2008 May; 11(5):3. PubMed ID: 18688972
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diabetes mellitus related common medical disorders: recent progress in diagnosis and treatment. Topics: I. Pathophysiology, diagnosis and treatment; 11. Atherosclerosis].
    Watada H
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):902-6. PubMed ID: 23772505
    [No Abstract]   [Full Text] [Related]  

  • 7. Resistant hypertension and aldosterone: an update.
    Clark D; Ahmed MI; Calhoun DA
    Can J Cardiol; 2012 May; 28(3):318-25. PubMed ID: 22521297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Aldosteronism: Novel Insights.
    Stavropoulos K; Imprialos K; Papademetriou V; Faselis C; Tsioufis K; Dimitriadis K; Doumas M
    Curr Hypertens Rev; 2020; 16(1):19-23. PubMed ID: 30987572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary aldosteronism. A common cause of curable hypertension?].
    Juhlin C; Hägg A; Rastad J
    Lakartidningen; 1997 Feb; 94(9):723-6. PubMed ID: 9091747
    [No Abstract]   [Full Text] [Related]  

  • 10. Anterior ischemic optic neuropathy associated with idiopathic aldosteronism and hypertension.
    Taniai M; Mizota A; Adachi-Usami E; Tatsuno I
    Ophthalmologica; 2002; 216(1):68-70. PubMed ID: 11901293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of primary aldosteronism.
    Boscaro M; Ronconi V; Turchi F; Giacchetti G
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):332-8. PubMed ID: 18594273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary aldosteronism: are we missing the wood for the trees?
    Funder JW
    Horm Metab Res; 2012 Mar; 44(3):251-3. PubMed ID: 22281545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of primary aldosteronism.
    Mulatero P; Monticone S; Bertello C; Tizzani D; Iannaccone A; Crudo V; Veglio F
    Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):188-93. PubMed ID: 20389241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monogenic mineralocorticoid hypertension.
    Stowasser M; Gordon RD
    Best Pract Res Clin Endocrinol Metab; 2006 Sep; 20(3):401-20. PubMed ID: 16980202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of new-onset diabetes mellitus in primary aldosteronism: a population study over 5 years.
    Wu VC; Chueh SJ; Chen L; Chang CH; Hu YH; Lin YH; Wu KD; Yang WS;
    J Hypertens; 2017 Aug; 35(8):1698-1708. PubMed ID: 28661412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment refractory hypertension with atrophic kidney: attending to one and not neglecting the other].
    Guertler M; Vetter W; Suter PM
    Praxis (Bern 1994); 2003 Jan; 92(4):139-42. PubMed ID: 12632844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary aldosteronism.
    Auchus RJ; Nwariaku FE
    Curr Cardiol Rep; 2007 Nov; 9(6):447-52. PubMed ID: 17999869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary hyperaldosteronism: should we pose its systematic detection at health centres?].
    Maciá-Bobes C; Ronzón-Fernández A; Castaño-Fernández G; Botas-Cervero P
    Aten Primaria; 2006 Feb; 37(2):104-7. PubMed ID: 16527118
    [No Abstract]   [Full Text] [Related]  

  • 19. [How to unravel hyperaldosteronism in clinical practice].
    van der Giet M
    MMW Fortschr Med; 2014 Oct; 156(17):61-2. PubMed ID: 25417478
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.